Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(±)13-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro. It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes. Fresh water hydra was shown to metabolize DHA to 13(R)-HDHA, presumably via the 11R-lipoxygenase activity. (±)13-HDHA is a potential marker of oxidative stress in brain and retina where DHA is an abundant polyunsaturated fatty acid.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 μg | 35 days | $ 143.00 | |
50 μg | 35 days | $ 270.00 | |
100 μg | 35 days | $ 494.00 | |
250 μg | 35 days | $ 1,190.00 |
Description | (±)13-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro. It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes. Fresh water hydra was shown to metabolize DHA to 13(R)-HDHA, presumably via the 11R-lipoxygenase activity. (±)13-HDHA is a potential marker of oxidative stress in brain and retina where DHA is an abundant polyunsaturated fatty acid. |
Molecular Weight | 344.495 |
Formula | C22H32O3 |
CAS No. | 90780-53-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: Miscible
PBS (pH 7.2): 0.8 mg/mL
0.1 M Na2CO3: 2 mg/mL
DMSO: Miscible
DMF: Miscible
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(±)13-HDHA 90780-53-3 (±)13HDHA 13-HDHA (±)13 HDHA inhibitor inhibit